STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 43 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $426,000 | +18.0% | 143,577 | +9.6% | 0.01% | 0.0% |
| Q1 2021 | $361,000 | -46.0% | 130,948 | -52.4% | 0.01% | -44.0% |
| Q4 2020 | $669,000 | -16.1% | 275,337 | -27.4% | 0.02% | -47.9% |
| Q3 2020 | $797,000 | -44.8% | 379,398 | -0.8% | 0.05% | -51.5% |
| Q2 2020 | $1,445,000 | +96.9% | 382,400 | -1.5% | 0.10% | +62.3% |
| Q1 2020 | $734,000 | +95.2% | 388,309 | +223.6% | 0.06% | +79.4% |
| Q2 2019 | $376,000 | -24.5% | 120,000 | +20.0% | 0.03% | -29.2% |
| Q1 2019 | $498,000 | +113.7% | 100,000 | +92.3% | 0.05% | +41.2% |
| Q4 2018 | $233,000 | – | 52,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 978,907 | $6,865,000 | 3.28% |
| RA Capital Management | 2,690,702 | $20,449,000 | 2.02% |
| NEA Management Company, LLC | 2,141,308 | $16,274,000 | 1.04% |
| Broadfin Capital, LLC | 1,656,705 | $10,911,000 | 0.67% |
| Tredje AP-fonden | 909,581 | $6,913,000 | 0.44% |
| Granite Point Capital Management, L.P. | 388,945 | $2,679,000 | 0.40% |
| Ghost Tree Capital, LLC | 72,726 | $553,000 | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 181,818 | $1,382,000 | 0.20% |
| Tower Research Capital LLC (TRC) | 1,094 | $8,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,373 | $10,000 | 0.00% |